These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8941286)
1. High-titer immunoglobulin M antibody to nerve-specific class III beta-tubulin in the serum of a patient with sensory demyelinating polyneuropathy. Stubbs EB; Fisher MA; Wilson JR; Siegel GJ Muscle Nerve; 1996 Dec; 19(12):1638-9. PubMed ID: 8941286 [No Abstract] [Full Text] [Related]
3. Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathy. Connolly AM; Pestronk A; Mehta S; Yee WC; Green BJ; Fellin C; Olney RK; Miller RG; Devor WN Neurology; 1997 Jan; 48(1):243-8. PubMed ID: 9008525 [TBL] [Abstract][Full Text] [Related]
4. The 301 to 314 amino acid residue of beta-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy. Tagawa Y; Yuki N; Hirata K J Neurol Sci; 1999 Feb; 163(1):44-6. PubMed ID: 10223409 [TBL] [Abstract][Full Text] [Related]
5. Serum antibodies against central nervous system proteins in human demyelinating disease. Newcombe J; Gahan S; Cuzner ML Clin Exp Immunol; 1985 Feb; 59(2):383-90. PubMed ID: 2579754 [TBL] [Abstract][Full Text] [Related]
6. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy. Bech E; Andersen H; Orntoft TF; Jakobsen J Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770 [TBL] [Abstract][Full Text] [Related]
14. Three different anti-myelin antibodies in a case of demyelinating dysglobulinemic peripheral neuropathy. Ellie E; Younes-Chennoufi AB; Couto A; Vital A; Hilmi S; Demotes-Mainard J; Baumann N; Petry KG J Peripher Nerv Syst; 1997; 2(1):43-8. PubMed ID: 10975735 [TBL] [Abstract][Full Text] [Related]
15. Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders. Rostami AM; Burns JB; Eccleston PA; Manning MC; Lisak RP; Silberberg DH Ann Neurol; 1987 Sep; 22(3):381-3. PubMed ID: 3674803 [TBL] [Abstract][Full Text] [Related]
16. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study. Smith IS Brain; 1994 Oct; 117 ( Pt 5)():949-57. PubMed ID: 7953604 [TBL] [Abstract][Full Text] [Related]
17. Antibody formation against beta-tubulin class III in response to brain trauma. Skoda D; Kranda K; Bojar M; Glosová L; Bäurle J; Kenney J; Romportl D; Pelichovská M; Cvachovec K Brain Res Bull; 2006 Jan; 68(4):213-6. PubMed ID: 16377426 [TBL] [Abstract][Full Text] [Related]
18. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Dalakas MC; Quarles RH; Farrer RG; Dambrosia J; Soueidan S; Stein DP; Cupler E; Sekul EA; Otero C Ann Neurol; 1996 Nov; 40(5):792-5. PubMed ID: 8957021 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of the anti-IgM SGPG Elisa (Bühlmann laboratories AG) in 147 sera with a monoclonal IgM anti-MAG/SGPG antibody-associated neuropathy]. Caudie C; Bouhour F; Petiot P; Gonnaud PM; Antoine JC; Vial C Ann Biol Clin (Paris); 2007; 65(4):369-75. PubMed ID: 17627917 [TBL] [Abstract][Full Text] [Related]
20. Chronic demyelinating neuropathy associated with antibodies to myelin associated glycoprotein. Steck AJ Riv Neurobiol; 1984; 30(2-3):179-86. PubMed ID: 6085774 [No Abstract] [Full Text] [Related] [Next] [New Search]